INHIBITOR Therapeutics Company Profile: Stock Performance & Earnings

INHIBITOR Therapeutics Overview

Founded
1992

Status
Public

Employees
2

Stock Symbol
INTI

Share Price
$0.04
(As of Tuesday Closing)

INHIBITOR Therapeutics General Information

Description

Inhibitor Therapeutics Inc is a pharmaceutical development company focused on developing and commercializing therapies for patients with cancer and non-cancerous proliferation disorders. The company's main focus is to advance its lead product, SUBA-Itraconazole a patented, oral formulation of the currently marketed, well-understood, anti-fungal drug, Itraconazole, for prostate and lung cancer.

Contact Information

Website

www.inhibitortx.com

Formerly Known As

Hedgepath Pharmaceuticals

Ownership Status

Publicly Held

Financing Status

Corporate Backed or Acquired

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery

Discovery Tools (Healthcare)

Stock Exchange

PINX

Primary Office

324 South Hyde Park Avenue
Suite 350
Tampa, FL 33606
United States

+1 (813) 000-0000





Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

INHIBITOR Therapeutics Stock Performance

(As of Tuesday Closing)

Stock Price	Previous Close	52 wk Range	Market Cap	Shares	Average Volume	EPS
$0.04	$0.04	$0.02 - $0.14	$13.9M	374M	26.7K

INHIBITOR Therapeutics Financials Summary

In Thousands, USD	TTM 30-Sep-2020	FY 2019 31-Dec-2019	FY 2018 31-Dec-2018	FY 2017 31-Dec-2017
EV	22,547	23,241	24,718	91,882
Revenue	0	0	0	0
EBITDA	(1,641)	(2,748)	(4,564)	(5,119)
Net Income	(1,638)	(2,733)	(4,550)	(5,101)
Total Assets	104	900	1,233	768
Total Debt	42	0	0	0

Public Fundamental Data provided by Morningstar, Inc. disclaimer

INHIBITOR Therapeutics Valuation & Funding

Deal Type	Date	Amount	Valuation/ EBITDA	Post-Val	Status	Debt

This information is available in the PitchBook Platform. To explore INHIBITOR Therapeutics‘s full profile, request access.

Request a free trial

INHIBITOR Therapeutics Comparisons

Description

Primary
Industry

HQ Location

Employees

Total Raised

Post Valuation

Last Financing Details

Inhibitor Therapeutics Inc is a pharmaceutical development company focused on developing and commercializing therapies f

Pharmaceuticals

Tampa, FL

2 As of 2020

0000

000000000 0000

00000 00

ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor i

0000 000000000

Carlsbad, CA

000 As of 0000

0000

0.000 0000-00-00

00000000000 0000

0000000

modo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugi

000000000000000

Dallas, TX

00 As of 0000

00000

0.000 0000-00-00

000000&0 00000

Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

INHIBITOR Therapeutics Competitors (35)

Company Name	Financing Status	Location	Employees	Total Raised	Last Financing Date/Type	Last Financing Amount
Ionis Pharmaceuticals	Corporate Backed or Acquired	Carlsbad, CA	000	0000	00000000000	0000
0000000 0000000000	Formerly VC-backed	Dallas, TX	00	00000	000000&0	00000
000000 000000	Formerly VC-backed	Marseille, France	000	00000	000000000	00000
000000000 (0000 00	Venture Capital-Backed	Stevenage, United Kingdom		000.00	00000000000	000.00
00 000000000000000	Formerly VC-backed	Cambridge, MA	00	00000	000000&0	00000